Jeremy Stepp’s Post

Did you know that up to 73% of adult cancer survivors experience financial toxicity, the damage inflicted on personal finances by medical costs? Additionally, almost half of breast cancer patients report that even mild financial toxicity affect treatment choices, quality of life, medication adherence, bankruptcy rates, and even mortality But did you know also know that there are plans such as living benefits that can take care of the financial burden of an illness and protect your quality of life? connect with us today to learn more about the living benefits plan 💻

Today is World Parkinson’s day, a day to raise awareness and remember those struggling with this debilitating disease. Every year 90,000 new patients are diagnosed with Parkinson’s Disease (PD), and about 6,000 patients a year seek Deep Brain Stimulation (DBS) as they become refractory to medication. DBS can be transformative for patients, extending their quality of life and functionality by up to 10 years or more. Alpha Omega’s mission is to help maximize treatment and get PD patients the best results from DBS working alongside neurosurgeons and neurologists. #ParkinsonsAwareness #DBS

As part of scientists’ efforts to find treatments for Alzheimer’s Disease, they have been investigating the build-up of fat droplets, and their toxicity, in certain brain cells in those diagnosed. By researching their build-up, and the harm they cause, in different patients with different forms of Alzheimer’s, there is now a greater understanding of the connection between development and progression of the Disease which allows for further investigation of ways to mitigate their impact. You can read the full lay summary from Hollie Wareing at https://lnkd.in/ep8T9cPA

Set your calendar for October 21, 2024 at 11:00 AM, because we have a new webinar! Next week we will be joined by Dr John Pauling, a Consultant Rheumatologist at North Bristol NHS Trust who will lead a webinar about 'Exploring Raynaud's Phenomenon.' We recently spoke to Dr John Pauling who gave us a taster of what you can expect from the webinar. Find out below what he had to say: ''In the webinar, I will discuss the different forms of Raynaud’s phenomenon, highlighting some of the complexity of what we currently term primary Raynaud’s phenomenon. I will discuss the various methods we use to differentiate between primary RP and RP secondary to autoimmune disease such as SSc. I will also discuss how the term Raynaud’s phenomenon may be contributing to diagnostic delay in systemic sclerosis.'' Register now: https://bit.ly/4dJeQ6S

The PrecivityAD2 test delivers confirmatory diagnostic performance comparable to CSF biomarkers and Amyloid PET to identify the presence or absence of amyloid pathology. The ability to test for Alzheimer’s Disease (AD) using a simple peripheral blood venipuncture sample greatly expands the practical availability of AD testing to many more people, including those traditionally difficult to reach because of physical location and or other limitations, than current methods of testing. People do not necessarily need to travel great distances, have access to a subspecialist, and or have expensive equipment present in order to be tested. #AD #Alzheimer #PrecivityAD2 #PET #PositronEmissionTomography #venipuncture #peripheralblood #healthaccess #CSF #cerebrospinalfluid #AlzheimerDisease #C2NDiagnostics #C2N

Research in the medical field plays a crucial role in advancing community health and societal well-being. Recent studies, such as those evaluating blood tests for Alzheimer's disease, demonstrate the potential to revolutionize diagnostic and treatment approaches. Accurate diagnostic tools can lead to earlier and more effective interventions, ultimately improving patient outcomes. By continuously exploring new technologies and methodologies, medical research not only enhances our understanding of diseases but also paves the way for innovations that can significantly benefit public health.

Learn about the importance of early diagnosis of Alzheimer’s disease from B. Joy Snider, MD, PhD. Discover how timely detection can positively impact patient outcomes and improve their journey. Don’t miss this insightful discussion on early intervention. Watch here: https://bit.ly/4aB0HqZ #EarlyDetection

🧠 Early Diagnosis Saves Lives! 🧠 Detecting spinal cord tumors early can make a world of difference. Early diagnosis allows for more treatment options and can prevent permanent damage to the spinal cord. Here’s why it’s crucial: 🔍 Better Treatment Outcomes: Early detection often means the tumor is smaller and more manageable, leading to more effective treatments. 🩺 Prevent Permanent Damage: Catching the tumor early can help avoid irreversible damage to the spinal cord, preserving mobility and function. 💡 Awareness is Key: Know the signs and symptoms, such as unexplained back pain, numbness, or weakness. Don’t ignore persistent symptoms! 👩⚕️ Regular Check-ups: Regular medical check-ups can help in early detection, especially if you have risk factors. Spread the word and stay informed! Early diagnosis can save lives and improve quality of life. 💪 #SpinalCordTumor #EarlyDiagnosis #HealthAwareness #MedicalAdvancements #StayInformed Feel free to customize it to better fit your style or audience! 😊

Sharing our recently published paper on Isaacs Syndrome. In this paper, we documented a rare case of a patient with double-negative Isaacs syndrome with no associated autoimmune disorder nor malignancy on extensive diagnostic testing. We have also summarized the clinical features, interventions and outcomes of 4 other cases that had the similar features as our patient. You may check the abstract on this link below: https://lnkd.in/gdkk5dZt

Alzheimer disease commonly affects older people. But early-onset Alzheimer disease can affect people in their 30s or 40s. There is no known cure, but early diagnosis and treatment can lead to better quality of life. Read more key points about the detection of early-onset Alzheimer’s Disease at https://lnkd.in/eiJMKWnd.